Journal of Antimicrobial Chemotherapy (2000) 45, 167-173
© 2000 The British Society for Antimicrobial Chemotherapy
Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates
a Department of Microbiology, University Hospital Antwerp, Universitaire Instelling Antwerpen, Universiteitsplein 1, B-2610 Wilrijk, Antwerp; b University of Gent, Laboratory of Microbiology, Gent, Belgium
Resistance of streptococci to macrolide antibiotics is caused by target-site modification or drug efflux. The phenotypic expression of target-site modification can be inducible or constitutive. The prevalence of the three phenotypes among Belgian erythromycin-resistant Group A streptococci (GAS) and Streptococcus pneumoniae isolates was surveyed, their MICs for seven antibiotics were determined and the clonality of the isolates was explored. Of the 2014 GAS isolates tested 131(6.5%) were erythromycin resistant (MIC > 1 mg/L): 110 (84.0%) showed the M-resistance phenotype whereas the remaining 21 strains (16.0%) were constitutively resistant. No inducibly resistant strains were detected. Of 100 S. pneumoniae isolates, 33 were erythromycin resistant (MIC > 1 mg/L). In contrast to the GAS isolates, only 9.1% of the 33 erythromycin-resistant S. pneumoniae isolates showed the M-resistance phenotype. The presence of mefA/E and ermB genes in the M-resistant and constitutively and inducibly resistant strains, respectively, was confirmed by PCR analysis. Genomic analysis based on pulsed-field gel electrophoresis (PFGE) using the restriction enzyme SfiI, revealed 54 different PFGE patterns among the 131 erythromycin-resistant GAS isolates, of which an M6 clone represented 16.0% of the strains; all other clones, exhibiting different M-types, represented <7% of the strains. The S. pneumoniae isolates also appeared to be polyclonally based, as determined by arbitrarily primed PCR. The macrolides miocamycin and rovamycin, the lincosamide clindamycin and the ketolide HMR 3647 showed excellent activity against the M-resistant GAS and S. pneumoniae strains.
* Corresponding author. Tel./Fax: +32-3-820-2663; E-mail: Herman.Goossens{at}uza.uia.ac.be
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Malhotra-Kumar, L. Van Heirstraeten, C. Lammens, S. Chapelle, and H. Goossens Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin J. Antimicrob. Chemother., May 1, 2009; 63(5): 886 - 894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Hawkyard and R. J. Koerner The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks J. Antimicrob. Chemother., March 1, 2007; 59(3): 347 - 358. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. A. Figueiredo, S. I. Aguiar, J. Melo-Cristino, and M. Ramirez DNA Methylase Activity as a Marker for the Presence of a Family of Phage-Like Elements Conferring Efflux-Mediated Macrolide Resistance in Streptococci Antimicrob. Agents Chemother., November 1, 2006; 50(11): 3689 - 3694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Littauer, D. A. Caugant, M. Sangvik, E. A. Hoiby, A. Sundsfjord, G. S. Simonsen, and the Norwegian Macrolide Study Group Macrolide-Resistant Streptococcus pyogenes in Norway: Population Structure and Resistance Determinants. Antimicrob. Agents Chemother., May 1, 2006; 50(5): 1896 - 1899. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. M. D'Costa, K. M. McGrann, D. W. Hughes, and G. D. Wright Sampling the Antibiotic Resistome Science, January 20, 2006; 311(5759): 374 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Haller, K. Fluegge, S. J. Arri, B. Adams, and R. Berner Association between Resistance to Erythromycin and the Presence of the Fibronectin Binding Protein F1 Gene, prtF1, in Streptococcus pyogenes Isolates from German Pediatric Patients Antimicrob. Agents Chemother., July 1, 2005; 49(7): 2990 - 2993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Littauer, M. Sangvik, D. A. Caugant, E. A. Hoiby, G. S. Simonsen, A. Sundsfjord, and the Norwegian Macrolide Study Group Molecular Epidemiology of Macrolide-Resistant Isolates of Streptococcus pneumoniae Collected from Blood and Respiratory Specimens in Norway J. Clin. Microbiol., May 1, 2005; 43(5): 2125 - 2132. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. W. Klaassen and J. W. Mouton Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E) Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1271 - 1278. [Full Text] [PDF]
|
|
|
|
|
|
S. Malhotra-Kumar, C. Lammens, S. Chapelle, C. Mallentjer, J. Weyler, and H. Goossens Clonal spread of fluoroquinolone non-susceptible Streptococcus pyogenes J. Antimicrob. Chemother., March 1, 2005; 55(3): 320 - 325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Desjardins, K. L. Delgaty, K. Ramotar, C. Seetaram, and B. Toye Prevalence and Mechanisms of Erythromycin Resistance in Group A and Group B Streptococcus: Implications for Reporting Susceptibility Results J. Clin. Microbiol., December 1, 2004; 42(12): 5620 - 5623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kresken, B. Henrichfreise, S. Bagel, J. Brauers, and B. Wiedemann High Prevalence of the ermB Gene among Erythromycin-Resistant Streptococcus pneumoniae Isolates in Germany during the Winter of 2000-2001 and In Vitro Activity of Telithromycin Antimicrob. Agents Chemother., August 1, 2004; 48(8): 3193 - 3195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Farrell, I. Morrissey, S. Bakker, L. Morris, S. Buckridge, and D. Felmingham Molecular Epidemiology of Multiresistant Streptococcus pneumoniae with Both erm(B)- and mef(A)-Mediated Macrolide Resistance J. Clin. Microbiol., February 1, 2004; 42(2): 764 - 768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Malhotra-Kumar, C. Lammens, A. Martel, C. Mallentjer, S. Chapelle, J. Verhoeven, M. Wijdooghe, F. Haesebrouck, and H. Goossens Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium J. Antimicrob. Chemother., February 1, 2004; 53(2): 271 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Malhotra-Kumar, S. Wang, C. Lammens, S. Chapelle, and H. Goossens Bacitracin-Resistant Clone of Streptococcus pyogenes Isolated from Pharyngitis Patients in Belgium J. Clin. Microbiol., November 1, 2003; 41(11): 5282 - 5284. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Durmaz, B. Durmaz, M. Bayraktar, I. H. Ozerol, M. T. Kalcioglu, E. Aktas, and Z. Cizmeci Prevalence of Group A Streptococcal Carriers in Asymptomatic Children and Clonal Relatedness among Isolates in Malatya, Turkey J. Clin. Microbiol., November 1, 2003; 41(11): 5285 - 5287. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Martynova and V. B. Turcutyuicov Macrolide Resistance in Streptococcus pneumoniae Strains Collected in the Far East of Russia from 2000 to 2002 J. Clin. Microbiol., October 1, 2003; 41(10): 4906 - 4906. [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Clark and E. Langston Ketolides: A New Class of Antibacterial Agents for Treatment of Community-Acquired Respiratory Tract Infections in a Primary Care Setting Mayo Clin. Proc., September 1, 2003; 78(9): 1113 - 1124. [Abstract] [PDF]
|
|
|
|
|
|
D. J. Farrell, S. Douthwaite, I. Morrissey, S. Bakker, J. Poehlsgaard, L. Jakobsen, and D. Felmingham Macrolide Resistance by Ribosomal Mutation in Clinical Isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 Study Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1777 - 1783. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pihlajamaki, J. Jalava, P. Huovinen, and P. Kotilainen Antimicrobial Resistance of Invasive Pneumococci in Finland in 1999-2000 Antimicrob. Agents Chemother., June 1, 2003; 47(6): 1832 - 1835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Morrissey, D. J. Farrell, S. Bakker, S. Buckridge, and D. Felmingham Molecular Characterization and Antimicrobial Susceptibility of Fluoroquinolone-Resistant or -Susceptible Streptococcus pneumoniae from Hong Kong Antimicrob. Agents Chemother., April 1, 2003; 47(4): 1433 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Montanari, M. Mingoia, I. Cochetti, and P. E. Varaldo Phenotypes and Genotypes of Erythromycin-Resistant Pneumococci in Italy J. Clin. Microbiol., January 1, 2003; 41(1): 428 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Sauermann, R. Gattringer, W. Graninger, A. Buxbaum, and A. Georgopoulos Phenotypes of macrolide resistance of group A streptococci isolated from outpatients in Bavaria and susceptibility to 16 antibiotics J. Antimicrob. Chemother., January 1, 2003; 51(1): 53 - 57. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Amezaga, P. E. Carter, P. Cash, and H. McKenzie Molecular Epidemiology of Erythromycin Resistance in Streptococcus pneumoniae Isolates from Blood and Noninvasive Sites J. Clin. Microbiol., September 1, 2002; 40(9): 3313 - 3318. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Pihlajamaki, T. Kaijalainen, P. Huovinen, J. Jalava, and the Finnish Study Group for Antimicrobial Resistan Rapid increase in macrolide resistance among penicillin non-susceptible pneumococci in Finland, 1996-2000 J. Antimicrob. Chemother., May 1, 2002; 49(5): 785 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Martin, M. Green, K. A. Barbadora, and E. R. Wald Erythromycin-Resistant Group A Streptococci in Schoolchildren in Pittsburgh N. Engl. J. Med., April 18, 2002; 346(16): 1200 - 1206. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Nagai, P. C. Appelbaum, T. A. Davies, L. M. Kelly, D. B. Hoellman, A. T. Andrasevic, L. Drukalska, W. Hryniewicz, M. R. Jacobs, J. Kolman, et al. Susceptibilities to Telithromycin and Six Other Agents and Prevalence of Macrolide Resistance Due to L4 Ribosomal Protein Mutation among 992 Pneumococci from 10 Central and Eastern European Countries Antimicrob. Agents Chemother., February 1, 2002; 46(2): 371 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R. Reinert, A. Al-Lahham, M. Lemperle, C. Tenholte, C. Briefs, S. Haupts, H. H. Gerards, and R. Lutticken Emergence of macrolide and penicillin resistance among invasive pneumococcal isolates in Germany J. Antimicrob. Chemother., January 1, 2002; 49(1): 61 - 68. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Farrell, I. Morrissey, S. Bakker, and D. Felmingham Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization J. Antimicrob. Chemother., October 1, 2001; 48(4): 541 - 544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-I. Morosini, R. Canton, E. Loza, M.-C. Negri, J.-C. Galan, F. Almaraz, and F. Baquero In Vitro Activity of Telithromycin against Spanish Streptococcus pneumoniae Isolates with Characterized Macrolide Resistance Mechanisms Antimicrob. Agents Chemother., September 1, 2001; 45(9): 2427 - 2431. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ip, D. J. Lyon, R. W. H. Yung, C. Chan, and A. F. B. Cheng Macrolide Resistance in Streptococcus pneumoniae in Hong Kong Antimicrob. Agents Chemother., May 1, 2001; 45(5): 1578 - 1580. [Abstract] [Full Text]
|
|
|
|
|
|
R. R. Reinert, S. Simic, A. Al-Lahham, S. Reinert, M. Lemperle, and R. Lütticken Antimicrobial Resistance of Streptococcus pneumoniae Recovered from Outpatients with Respiratory Tract Infections in Germany from 1998 to 1999: Results of a National Surveillance Study J. Clin. Microbiol., March 1, 2001; 39(3): 1187 - 1189. [Abstract] [Full Text]
|
|